Ezetimibe Impurity 8 Enantiomer is the non-therapeutic stereoisomer of Ezetimibe, differing in configuration at the chiral center adjacent to the tetrahydrofuran ring. It retains the 4-(4-fluorophenyl)-1,3-oxazol-5-yl moiety but exhibits inverted stereochemistry at the stereocenter linking the oxazole and tetrahydrofuran substituents. This enantiomer arises during asymmetric synthesis or racemic resolution processes. It serves as a critical HPLC reference standard for enantioselective purity analysis of Ezetimibe APIs.
On RequestC1[C@H](N(C(=O)O1)C(=O)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=C3
InChI=1S/C20H18FNO4/c21-16-11-9-15(10-12-16)18(23)7-4-8-19(24)22-17(13-26-20(22)25)14-5-2-1-3-6-14/h1-3,5-6,9-12,17H,4,7-8,13H2/t17-/m0/s1
XXSSRSVXDNUAQX-KRWDZBQOSA-N